
Syneos Health, Inc. Class A Common Stock
SYNH
SYNH: Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
moreShow SYNH Financials
Recent trades of SYNH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SYNH's directors and management
Government lobbying spending instances
-
$30,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Apr 20, 2023 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 20, 2023 Issue: Government Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Oct 20, 2022 Issue: Government Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jul 20, 2022 Issue: Government Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 20, 2022 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs
-
$30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Pharmacy
-
$30,000 Jul 20, 2021 Issue: Health Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues Pharmacy
-
$30,000 Jan 21, 2021 Issue: Health Issues Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Oct 20, 2020 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues
-
$30,000 Jul 20, 2020 Issue: Pharmacy Medical/Disease Research/Clinical Labs Health Issues
New patents grants
-
Patent Title: Intra-ocular lens for extended macular vision in patients with macular degeneration Aug. 08, 2023
-
Patent Title: Intraocular lens system Apr. 25, 2023
-
Patent Title: Intraocular lens for extended macular vision in patients with macular degeneration Oct. 19, 2021
-
Patent Title: Intraocular lens system Mar. 30, 2021
Federal grants, loans, and purchases
Followers on SYNH's company Twitter account
Number of mentions of SYNH in WallStreetBets Daily Discussion
Recent insights relating to SYNH
Recent picks made for SYNH stock on CNBC
ETFs with the largest estimated holdings in SYNH
Flights by private jets registered to SYNH